Request a Quote

Cyprotex Highlights - March 2020


Cyprotex's UK and US Sites Remain Open for Business

Both our Alderley Park (UK) and Watertown (USA) sites are operational and continue to serve our clients during this difficult time. 

Read Evotec’s latest statement on the current
COVID-19 situation:

Read the statement


New White Paper:
The Future of MEA in Early Toxicology Assessment

Learn more about microelectrode array technology (MEA) and the role it plays in early toxicology assessment.

Read our comprehensive 14 page review article.

Download the paper


Optimal In Vitro Screening Approaches for Detecting
Early CNS Liability

Read our latest blog to learn more about our recent research poster - originally planned for SOT 2020.

The poster highlights the advantages of using a combined in vitro screening approach for effectively identifying early CNS liability. 

Read the blog

Latest News from our Parent Company, Evotec

Read the latest news from parent company, Evotec:

  • Evotec SE reports 2019 financial results and corporate update
  • Ildong gains access to Evotec’s INDiGO platform to accelerate the development of various proprietary projects.
  • Evotec's partner Forge Therapeutics Inc. announces research collaboration with Roche to develop novel antibiotic
  • Global collaboration launched in fight against tuberculosis

Read the press releases

  • Read Evotec's new whitepaper on
    'Drug Abuse Liability Assessment'

Download the paper

Read the news
Contact us

News categories


Contact us to discuss your ADME Tox issues or request a quote

Europe: +44 (0)1625 505100
North America (East Coast): +1-888-297-7683

or fill out the form below:


Download file